Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Kingos Dyreklinik ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   4.6% 2.9% 9.6% 10.9% 7.1% 9.3% 21.0% 20.6%   Credit score (0-100)   48 59 25 21 33 25 5 5   Credit rating   BBB BBB BB BB BBB BB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   710 860 786 723 762 652 0.0 0.0   EBITDA   373 137 -80.7 -111 219 60.3 0.0 0.0   EBIT   365 129 -88.6 -119 211 60.3 0.0 0.0   Pre-tax profit (PTP)   364.5 130.2 -90.6 -119.7 210.2 63.7 0.0 0.0   Net earnings   284.1 101.4 -90.3 -119.7 209.9 46.7 0.0 0.0   Pre-tax profit without non-rec. items   364 130 -90.6 -120 210 63.7 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   32.0 24.0 16.0 8.0 0.0 0.0 0.0 0.0   Shareholders equity total   338 331 130 10.6 221 149 49.5 49.5   Interest-bearing liabilities   7.3 87.2 2.2 2.3 2.3 0.3 0.0 0.0   Balance sheet total (assets)   550 688 586 215 397 313 49.5 49.5   Net Debt   -469 -495 -220 -83.5 -318 -229 -49.5 -49.5     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   710 860 786 723 762 652 0.0 0.0   Gross profit growth   97.8% 21.2% -8.7% -8.0% 5.3% -14.4% -100.0% 0.0%   Employees   2 2 2 2 2 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% -50.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   550 688 586 215 397 313 49 49   Balance sheet change%   129.6% 25.0% -14.8% -63.4% 85.0% -21.3% -84.2% 0.0%   Added value   372.8 137.3 -80.7 -111.1 219.3 60.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   24 -16 -16 -16 -16 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 -1.0 -2.0 1.0 2.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   51.4% 15.0% -11.3% -16.5% 27.8% 9.3% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   92.5% 21.3% -13.9% -29.7% 69.1% 18.0% 0.0% 0.0%   ROI %   142.5% 33.0% -30.3% -163.6% 179.3% 34.3% 0.0% 0.0%   ROE %   114.4% 30.3% -39.1% -169.8% 181.6% 25.2% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   61.4% 48.2% 22.2% 5.0% 55.5% 47.8% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -125.9% -360.6% 273.2% 75.2% -145.0% -379.6% 0.0% 0.0%   Gearing %   2.2% 26.3% 1.7% 21.6% 1.0% 0.2% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   10.9% 3.2% 5.0% 28.8% 53.1% 16.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   2.4 2.0 1.2 0.8 2.1 1.9 0.0 0.0   Current Ratio   2.4 2.1 1.3 1.0 2.2 1.9 0.0 0.0   Cash and cash equivalent   476.7 582.4 222.6 85.8 320.3 229.3 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   306.3 340.3 114.4 2.7 220.6 149.5 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   186 69 -40 -56 110 60 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   186 69 -40 -56 110 60 0 0   EBIT / employee   182 65 -44 -60 106 60 0 0   Net earnings / employee   142 51 -45 -60 105 47 0 0